The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Angiogenic ELR<sup>+</sup> chemokines</td><td align="center">Antiangiogenic non-ELR<sup>+</sup> chemokines</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">CXCL1</td><td align="center">CXCL4</td></tr><tr><td align="left">CXCL2</td><td align="center">CXCL9</td></tr><tr><td align="left">CXCL3</td><td align="center">CXCL10</td></tr><tr><td align="left">CXCL5</td><td align="center">CXCL11</td></tr><tr><td align="left">CXCL6</td><td align="center">CXCL14</td></tr><tr><td align="left">CXCL7</td><td align="center"> </td></tr><tr><td align="left">CXCL8</td><td align="center"> </td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Angiogenic and antiangiogenic members of CXC chemokine family.

Journal of Immunology Research

tab1

Table 1

Table 1: The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets 